Symbol="ARVN"
AssetType="Common Stock"
Name="Arvinas Inc"
Description="Arvinas, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of therapies to break down disease-causing proteins. The company is headquartered in New Haven, Connecticut."
CIK="1655759"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1217484000"
EBITDA="-287200000"
PERatio="None"
PEGRatio="None"
BookValue="9.57"
DividendPerShare="0"
DividendYield="0"
EPS="-4.78"
RevenuePerShareTTM="2.579"
ProfitMargin="-2.191"
OperatingMarginTTM="-2.134"
ReturnOnAssetsTTM="-0.138"
ReturnOnEquityTTM="-0.488"
RevenueTTM="137400000"
GrossProfitTTM="131400000"
DilutedEPSTTM="-4.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.226"
AnalystTargetPrice="70.05"
TrailingPE="-"
ForwardPE="17.7"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="3.129"
EVToRevenue="6.07"
EVToEBITDA="-2.861"
Beta="1.756"
num_52WeekHigh="58.58"
num_52WeekLow="21.21"
num_50DayMovingAverage="24.97"
num_200DayMovingAverage="33.49"
SharesOutstanding="53398000"
DividendDate="None"
ExDividendDate="None"
symbol="ARVN"
open="22.77"
high="23.34"
low="22.63"
price="22.89"
volume="389094.00"
latest_trading_day="2023-07-10"
previous_close="22.80"
change="0.09"
change_percent="0.3947%"
aroon_positive_momentum_days="18"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="458525"
Change_recent_avg="-0.12"
Delta_recent_avg="1.59"
Variance_recent_avg="0.8"
Change_ratio_recent_avg="-0.53"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="1105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_negative_thumbnail_id_2="510"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_neutral_thumbnail_id_1="575"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="606"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_positive_thumbnail_id_2="672"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1187"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
